Literature DB >> 8147622

Impact of mammary grafts on coronary bypass operative mortality and morbidity. Department of Veterans Affairs Cardiac Surgeons.

F L Grover1, R R Johnson, G Marshall, K E Hammermeister.   

Abstract

The internal mammary artery is frequently used as a coronary artery bypass graft conduit because of superior long-term patency. The purpose of this study was to determine if there was also an advantage to the internal mammary artery in terms of operative mortality and morbidity. The Department of Veterans Affairs Cardiac Surgery Database was reviewed for two separate time periods, April 1987 through March 1989 and October 1990 through September 1991. During these periods, 14,172 patients underwent coronary artery bypass grafting. Univariate and multivariate logistic regression analyses were used to determine preoperative variables predictive of operative mortality and morbidity, with the independent variable of use of the internal mammary artery added to previously determined indicators. The total group was analyzed in risk quartiles according to expected mortality. Univariate analysis revealed an operative mortality of 6.8% in the early period and 6.5% in the latter period for the saphenous vein groups compared with 3.7% and 3.2%, respectively, for the internal mammary artery groups (p = 0.000). Multivariate analysis revealed an odds ratio of operative death with use of the internal mammary artery graft versus use of vein grafts of 0.78 during the first period and 0.72 during the second period, reductions of 22% and 28%, respectively. There were 29% and 37% reductions in the odds of operative mortality in the highest-risk quartile group of patients using the internal mammary artery graft. The odds ratio of developing mediastinitis with one internal mammary artery graft was 1.84 (p < 0.01) in the first time period and 1.11 in the second time period (p = not significant). However, with multiple mammary bypass grafts, the odds ratios were 3.70 (p < 0.01) and 2.96 (p < 0.01) in the respective time periods. On the basis of this study, it is concluded that internal mammary artery grafts in addition to providing superior long-term patency also decreased operative mortality after adjustment for patient risk factors. Use of the mammary artery does not consistently increase operative complications with the exception of mediastinitis when both internal mammary arteries are employed.

Entities:  

Mesh:

Year:  1994        PMID: 8147622     DOI: 10.1016/0003-4975(94)90546-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  13 in total

Review 1.  Coronary revascularization in the 21st century. Emphasis on contributions by Japanese surgeons.

Authors:  Hendrick B Barner
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-12

2.  The effect of not using an internal mammary artery as a conduit for coronary artery bypass grafting.

Authors:  B J Leavitt
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

3.  Laser Doppler flowmetry assessment of peristernal perfusion after cardiac surgery: beneficial effect of negative pressure therapy.

Authors:  Broadus Zane Atkins; Jean K Tetterton; Rebecca P Petersen; Kista Hurley; Walter G Wolfe
Journal:  Int Wound J       Date:  2010-12-17       Impact factor: 3.315

4.  Effect of graft adaptation of the internal mammary artery on longitudinal phasic blood flow velocity characteristics after surgery.

Authors:  Setsuo Kumazaki; Jun Koyama; Kazunori Aizawa; Hiroki Kasai; Megumi Koshikawa; Atsushi Izawa; Takeshi Tomita; Masafumi Takahashi; Uichi Ikeda
Journal:  Heart Vessels       Date:  2010-10-05       Impact factor: 2.037

Review 5.  Current status of coronary artery bypass grafting.

Authors:  Junjiro Kobayashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-06-18

6.  Suitability and durability of multiple internal thoracic artery coronary artery bypasses.

Authors:  J W Jones; S E Schmidt; R Miller; C Nahas; A C Beall
Journal:  Ann Surg       Date:  1997-06       Impact factor: 12.969

7.  Left internal mammary artery usage in coronary artery bypass grafting: a measure of quality control.

Authors:  S Karthik; B M Fabri
Journal:  Ann R Coll Surg Engl       Date:  2006-07       Impact factor: 1.891

8.  A decade's experience with quality improvement in cardiac surgery using the Veterans Affairs and Society of Thoracic Surgeons national databases.

Authors:  F L Grover; A L Shroyer; K Hammermeister; F H Edwards; T B Ferguson; S W Dziuban; J C Cleveland; R E Clark; G McDonald
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

9.  Risk stratification analysis of operative mortality in coronary artery bypass surgery.

Authors:  Y Kawachi; A Nakashima; Y Toshima; I Komesu; S Kimura; K Arinaga
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-09

10.  Does a gentamicin-impregnated collagen sponge reduce sternal wound infections in high-risk cardiac surgery patients?

Authors:  Gabriel Birgand; Costin Radu; Soleiman Alkhoder; Nawwar Al Attar; Richard Raffoul; Marie-Pierre Dilly; Patrick Nataf; Jean-Christophe Lucet
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.